Software - Application
Compare Stocks
5 / 10Stock Comparison
TRAK vs VRNT vs SSYS vs NICE vs DDD
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Computer Hardware
Software - Application
Computer Hardware
TRAK vs VRNT vs SSYS vs NICE vs DDD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Infrastructure | Computer Hardware | Software - Application | Computer Hardware |
| Market Cap | $185M | $1.24B | $707M | $5.78B | $350M |
| Revenue (TTM) | $24M | $894M | $551M | $2.95B | $387M |
| Net Income (TTM) | $7M | $61M | $-104M | $612M | $64M |
| Gross Margin | 85.0% | 69.9% | 43.6% | 66.4% | 33.9% |
| Operating Margin | 30.2% | 8.6% | -11.7% | 21.9% | -24.8% |
| Forward P/E | 27.8x | 7.0x | 69.8x | 8.7x | 12.6x |
| Total Debt | $510K | $448M | $27M | $164M | $61M |
| Cash & Equiv. | $29M | $216M | $95M | $379M | $96M |
TRAK vs VRNT vs SSYS vs NICE vs DDD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ReposiTrak, Inc. (TRAK) | 100 | 198.3 | +98.3% |
| Verint Systems Inc. (VRNT) | 100 | 43.7 | -56.3% |
| Stratasys Ltd. (SSYS) | 100 | 45.9 | -54.1% |
| NICE Ltd. (NICE) | 100 | 51.4 | -48.6% |
| 3D Systems Corporat… (DDD) | 100 | 32.5 | -67.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRAK vs VRNT vs SSYS vs NICE vs DDD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRAK carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 14.5% 10Y total return vs NICE's 50.7%
- Lower volatility, beta 1.15, Low D/E 1.0%, current ratio 6.09x
- Beta 1.15, yield 0.9%, current ratio 6.09x
- 10.5% revenue growth vs DDD's -12.1%
VRNT ranks third and is worth considering specifically for income & stability.
- Dividend streak 0 yrs, beta 1.26, yield 1.6%
- 1.6% yield, vs TRAK's 0.9%, (3 stocks pay no dividend)
Among these 5 stocks, SSYS doesn't own a clear edge in any measured category.
NICE is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 7.7%, EPS growth 43.0%, 3Y rev CAGR 10.5%
- PEG 0.33 vs TRAK's 0.81
- Lower P/E (8.7x vs 12.6x)
- Beta 0.72 vs DDD's 3.12, lower leverage
DDD is the clearest fit if your priority is momentum.
- +22.2% vs TRAK's -52.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.5% revenue growth vs DDD's -12.1% | |
| Value | Lower P/E (8.7x vs 12.6x) | |
| Quality / Margins | 30.9% margin vs SSYS's -18.9% | |
| Stability / Safety | Beta 0.72 vs DDD's 3.12, lower leverage | |
| Dividends | 1.6% yield, vs TRAK's 0.9%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +22.2% vs TRAK's -52.5% | |
| Efficiency (ROA) | 12.9% ROA vs SSYS's -9.6%, ROIC 21.4% vs -5.8% |
TRAK vs VRNT vs SSYS vs NICE vs DDD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TRAK vs VRNT vs SSYS vs NICE vs DDD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TRAK leads in 3 of 6 categories
NICE leads 1 • VRNT leads 1 • SSYS leads 0 • DDD leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TRAK leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $2.9B annually — 125.3x TRAK's $24M. TRAK is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to SSYS's -18.9%. On growth, NICE holds the edge at +9.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $24M | $894M | $551M | $2.9B | $387M |
| EBITDAEarnings before interest/tax | $8M | $127M | -$32M | $845M | -$78M |
| Net IncomeAfter-tax profit | $7M | $61M | -$104M | $612M | $64M |
| Free Cash FlowCash after capex | $7M | $118M | -$8M | $665M | -$98M |
| Gross MarginGross profit ÷ Revenue | +85.0% | +69.9% | +43.6% | +66.4% | +33.9% |
| Operating MarginEBIT ÷ Revenue | +30.2% | +8.6% | -11.7% | +21.9% | -24.8% |
| Net MarginNet income ÷ Revenue | +30.9% | +6.9% | -18.9% | +20.8% | +16.7% |
| FCF MarginFCF ÷ Revenue | +29.1% | +13.2% | -1.4% | +22.6% | -25.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.7% | -1.0% | -6.9% | +9.0% | -4.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +13.2% | -5.1% | +62.7% | +56.5% | +116.0% |
Valuation Metrics
NICE leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 66% valuation discount to TRAK's 29.0x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.37x vs VRNT's 1.02x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $185M | $1.2B | $707M | $5.8B | $350M |
| Enterprise ValueMkt cap + debt − cash | $157M | $1.5B | $639M | $5.6B | $315M |
| Trailing P/EPrice ÷ TTM EPS | 29.01x | 19.72x | -6.41x | 9.89x | 12.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.82x | 7.00x | 69.79x | 8.74x | — |
| PEG RatioP/E ÷ EPS growth rate | 0.85x | 1.02x | — | 0.37x | — |
| EV / EBITDAEnterprise value multiple | 20.98x | 9.46x | — | 6.59x | — |
| Price / SalesMarket cap ÷ Revenue | 8.18x | 1.37x | 1.28x | 1.96x | 0.90x |
| Price / BookPrice ÷ Book value/share | 3.93x | 0.97x | 0.79x | 1.56x | 1.73x |
| Price / FCFMarket cap ÷ FCF | 22.01x | 8.75x | — | 8.22x | — |
Profitability & Efficiency
TRAK leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DDD delivers a 30.1% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $-12 for SSYS. TRAK carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRNT's 0.34x. On the Piotroski fundamental quality scale (0–9), TRAK scores 7/9 vs DDD's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.6% | +4.6% | -12.3% | +16.4% | +30.1% |
| ROA (TTM)Return on assets | +12.9% | +2.8% | -9.6% | +11.8% | +11.5% |
| ROICReturn on invested capital | +21.4% | +5.3% | -5.8% | +13.2% | -28.8% |
| ROCEReturn on capital employed | +12.9% | +5.9% | -6.6% | +16.1% | -22.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 6 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 0.34x | 0.03x | 0.04x | 0.25x |
| Net DebtTotal debt minus cash | -$28M | $233M | -$68M | -$216M | -$35M |
| Cash & Equiv.Liquid assets | $29M | $216M | $95M | $379M | $96M |
| Total DebtShort + long-term debt | $509,973 | $448M | $27M | $164M | $61M |
| Interest CoverageEBIT ÷ Interest expense | 165.50x | 8.24x | — | — | 51.44x |
Total Returns (Dividends Reinvested)
TRAK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TRAK five years ago would be worth $21,031 today (with dividends reinvested), compared to $1,247 for DDD. Over the past 12 months, DDD leads with a +22.2% total return vs TRAK's -52.5%. The 3-year compound annual growth rate (CAGR) favors TRAK at 17.7% vs DDD's -35.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.1% | — | -9.0% | -14.6% | +29.5% |
| 1-Year ReturnPast 12 months | -52.5% | +17.9% | -15.6% | -40.4% | +22.2% |
| 3-Year ReturnCumulative with dividends | +63.0% | -39.3% | -42.9% | -49.3% | -73.7% |
| 5-Year ReturnCumulative with dividends | +110.3% | -56.1% | -59.1% | -59.1% | -87.5% |
| 10-Year ReturnCumulative with dividends | +14.5% | -37.1% | -60.6% | +50.7% | -81.1% |
| CAGR (3Y)Annualised 3-year return | +17.7% | -15.3% | -17.0% | -20.2% | -35.9% |
Risk & Volatility
Evenly matched — VRNT and NICE each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than DDD's 3.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRNT currently trades 89.8% from its 52-week high vs TRAK's 42.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.15x | 1.26x | 1.79x | 0.72x | 3.12x |
| 52-Week HighHighest price in past year | $23.72 | $22.84 | $12.81 | $180.61 | $3.80 |
| 52-Week LowLowest price in past year | $6.94 | $16.23 | $7.34 | $94.89 | $1.32 |
| % of 52W HighCurrent price vs 52-week peak | +42.8% | +89.8% | +64.0% | +53.0% | +63.0% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 68.4 | 64.8 | 40.9 | 62.9 |
| Avg Volume (50D)Average daily shares traded | 161K | 0 | 818K | 631K | 2.7M |
Analyst Outlook
VRNT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: TRAK as "Buy", VRNT as "Hold", SSYS as "Buy", NICE as "Buy", DDD as "Hold". Consensus price targets imply 136.3% upside for TRAK (target: $24) vs 57.8% for NICE (target: $151). For income investors, VRNT offers the higher dividend yield at 1.56% vs TRAK's 0.85%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $24.00 | $32.57 | $13.50 | $150.88 | $5.00 |
| # AnalystsCovering analysts | 1 | 16 | 36 | 23 | 36 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.6% | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | — | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.09 | $0.32 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.7% | +5.8% | 0.0% | +8.5% | 0.0% |
TRAK leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NICE leads in 1 (Valuation Metrics). 1 tied.
TRAK vs VRNT vs SSYS vs NICE vs DDD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRAK or VRNT or SSYS or NICE or DDD a better buy right now?
For growth investors, ReposiTrak, Inc.
(TRAK) is the stronger pick with 10. 5% revenue growth year-over-year, versus -12. 1% for 3D Systems Corporation (DDD). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate ReposiTrak, Inc. (TRAK) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRAK or VRNT or SSYS or NICE or DDD?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus ReposiTrak, Inc. at 29. 0x. On forward P/E, Verint Systems Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 33x versus ReposiTrak, Inc. 's 0. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TRAK or VRNT or SSYS or NICE or DDD?
Over the past 5 years, ReposiTrak, Inc.
(TRAK) delivered a total return of +110. 3%, compared to -87. 5% for 3D Systems Corporation (DDD). Over 10 years, the gap is even starker: NICE returned +50. 7% versus DDD's -81. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRAK or VRNT or SSYS or NICE or DDD?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus 3D Systems Corporation's 3. 12β — meaning DDD is approximately 331% more volatile than NICE relative to the S&P 500. On balance sheet safety, ReposiTrak, Inc. (TRAK) carries a lower debt/equity ratio of 1% versus 34% for Verint Systems Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TRAK or VRNT or SSYS or NICE or DDD?
By revenue growth (latest reported year), ReposiTrak, Inc.
(TRAK) is pulling ahead at 10. 5% versus -12. 1% for 3D Systems Corporation (DDD). On earnings-per-share growth, the picture is similar: Verint Systems Inc. grew EPS 271. 4% year-over-year, compared to 20. 7% for ReposiTrak, Inc.. Over a 3-year CAGR, NICE leads at 10. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRAK or VRNT or SSYS or NICE or DDD?
ReposiTrak, Inc.
(TRAK) is the more profitable company, earning 30. 9% net margin versus -18. 9% for Stratasys Ltd. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRAK leads at 27. 5% versus -24. 8% for DDD. At the gross margin level — before operating expenses — TRAK leads at 83. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRAK or VRNT or SSYS or NICE or DDD more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 33x versus ReposiTrak, Inc. 's 0. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Verint Systems Inc. (VRNT) trades at 7. 0x forward P/E versus 69. 8x for Stratasys Ltd. — 62. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRAK: 136. 3% to $24. 00.
08Which pays a better dividend — TRAK or VRNT or SSYS or NICE or DDD?
In this comparison, VRNT (1.
6% yield), TRAK (0. 9% yield) pay a dividend. SSYS, NICE, DDD do not pay a meaningful dividend and should not be held primarily for income.
09Is TRAK or VRNT or SSYS or NICE or DDD better for a retirement portfolio?
For long-horizon retirement investors, ReposiTrak, Inc.
(TRAK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 0. 9% yield). 3D Systems Corporation (DDD) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TRAK: +14. 5%, DDD: -81. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRAK and VRNT and SSYS and NICE and DDD?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TRAK is a small-cap quality compounder stock; VRNT is a small-cap quality compounder stock; SSYS is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; DDD is a small-cap deep-value stock. TRAK, VRNT pay a dividend while SSYS, NICE, DDD do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.